NVO : Novo Nordisk A/S stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-17 |
|---|---|---|---|---|
| 2023 | $124.87 | $100.5 | $141.4 | -10.45% |
| 2024 | $90.72 | $87.13 | $95.94 | -34.94% |
| 2025 | $112.47 | $98.23 | $124.2 | -19.34% |
| 2026 | $148.27 | $125.58 | $177.23 | 6.33% |
| 2027 | $189.9 | $179.22 | $201.18 | 36.19% |
| 2028 | $205.77 | $202.7 | $206.95 | 47.57% |
| 2029 | $201.0 | $190.97 | $205.71 | 44.15% |
| 2030 | $139.06 | $86.17 | $186.4 | -0.27% |
| 2031 | $74.2 | $68.86 | $81.84 | -46.79% |
| 2032 | $91.79 | $80.54 | $98.47 | -34.17% |
| 2033 | $96.18 | $94.99 | $97.31 | -31.02% |
From AI system, total return is 2366.52% from 4098 forecasts.
For Novo Nordisk A/S stock forecast for 2023, 9 predictions are offered for each month of 2023 with average Novo Nordisk A/S stock
forecast of $124.87, a high forecast of $141.4, and a low forecast of $100.5.
The average Novo Nordisk A/S stock forecast 2023 represents a -10.45%
decrease from the last price of $139.440002441406.
For Novo Nordisk A/S stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Novo Nordisk A/S stock
forecast of $90.72, a high forecast of $95.94, and a low forecast of $87.13.
The average Novo Nordisk A/S stock forecast 2024 represents a -34.94%
decrease from the last price of $139.440002441406.
For Novo Nordisk A/S stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Novo Nordisk A/S stock
forecast of $148.27, a high forecast of $177.23, and a low forecast of $125.58.
The average Novo Nordisk A/S stock forecast 2026 represents a 6.33%
increase from the last price of $139.440002441406.
For Novo Nordisk A/S stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Novo Nordisk A/S stock
forecast of $205.77, a high forecast of $206.95, and a low forecast of $202.7.
The average Novo Nordisk A/S stock forecast 2028 represents a 47.57%
increase from the last price of $139.440002441406.
For Novo Nordisk A/S stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Novo Nordisk A/S stock
forecast of $74.2, a high forecast of $81.84, and a low forecast of $68.86.
The average Novo Nordisk A/S stock forecast 2031 represents a -46.79%
decrease from the last price of $139.440002441406.
For Novo Nordisk A/S stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average Novo Nordisk A/S stock
forecast of $96.18, a high forecast of $97.31, and a low forecast of $94.99.
The average Novo Nordisk A/S stock forecast 2033 represents a -31.02%
decrease from the last price of $139.440002441406.
Please, see more forecasts below.
NVO : Novo Nordisk A/S stock forecast by Wall Street Analysts
Novo Nordisk A/S stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-21 | $135.56 | -2.78% |
| 2023-03-22 | $135.58 | 0.02% |
| 2023-03-23 | $134.45 | -0.84% |
| 2023-03-24 | $134.71 | 0.20% |
| 2023-03-27 | $134.94 | 0.17% |
NVO : Long term Novo Nordisk A/S stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $141.40 , for 2024 Mar. is $87.90 , for 2027 Mar. is $182.41 , for 2028 Mar. is $205.29 , for 2032 Mar. is $86.39 , and for 2033 Mar. is $94.99.
NVO : Novo Nordisk A/S stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $141.40 | 1.41% |
| 2023 May. | $140.20 | -0.85% |
| 2023 Jun. | $137.12 | -2.20% |
| 2023 Jul. | $132.91 | -3.07% |
| 2023 Aug. | $127.71 | -3.91% |
| 2023 Sep. | $121.63 | -4.76% |
| 2023 Oct. | $114.78 | -5.63% |
| 2023 Nov. | $107.54 | -6.31% |
| 2023 Dec. | $100.50 | -6.55% |
NVO : Novo Nordisk A/S stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $94.51 | -5.95% |
| 2024 Feb. | $90.26 | -4.50% |
| 2024 Mar. | $87.90 | -2.62% |
| 2024 Apr. | $87.13 | -0.87% |
| 2024 May. | $87.42 | 0.33% |
| 2024 Jun. | $88.23 | 0.92% |
| 2024 Jul. | $89.23 | 1.14% |
| 2024 Aug. | $90.23 | 1.12% |
| 2024 Sep. | $91.29 | 1.17% |
| 2024 Oct. | $92.51 | 1.34% |
| 2024 Nov. | $93.99 | 1.60% |
| 2024 Dec. | $95.94 | 2.07% |
NVO : Novo Nordisk A/S stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $98.23 | 2.39% |
| 2025 Feb. | $100.93 | 2.75% |
| 2025 Mar. | $103.91 | 2.95% |
| 2025 Apr. | $106.70 | 2.68% |
| 2025 May. | $108.92 | 2.08% |
| 2025 Jun. | $111.43 | 2.30% |
| 2025 Jul. | $114.31 | 2.59% |
| 2025 Aug. | $117.13 | 2.47% |
| 2025 Sep. | $119.59 | 2.10% |
| 2025 Oct. | $121.49 | 1.59% |
| 2025 Nov. | $122.83 | 1.10% |
| 2025 Dec. | $124.20 | 1.12% |
NVO : Novo Nordisk A/S stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $125.58 | 1.11% |
| 2026 Feb. | $127.09 | 1.19% |
| 2026 Mar. | $128.91 | 1.43% |
| 2026 Apr. | $131.06 | 1.67% |
| 2026 May. | $134.03 | 2.26% |
| 2026 Jun. | $139.09 | 3.77% |
| 2026 Jul. | $148.16 | 6.52% |
| 2026 Aug. | $157.87 | 6.56% |
| 2026 Sep. | $165.09 | 4.58% |
| 2026 Oct. | $170.60 | 3.34% |
| 2026 Nov. | $174.50 | 2.29% |
| 2026 Dec. | $177.23 | 1.56% |
NVO : Novo Nordisk A/S stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $179.22 | 1.13% |
| 2027 Feb. | $180.85 | 0.91% |
| 2027 Mar. | $182.41 | 0.86% |
| 2027 Apr. | $184.12 | 0.94% |
| 2027 May. | $186.12 | 1.08% |
| 2027 Jun. | $188.36 | 1.21% |
| 2027 Jul. | $190.79 | 1.29% |
| 2027 Aug. | $193.19 | 1.26% |
| 2027 Sep. | $195.47 | 1.18% |
| 2027 Oct. | $197.57 | 1.08% |
| 2027 Nov. | $199.48 | 0.96% |
| 2027 Dec. | $201.18 | 0.85% |
NVO : Novo Nordisk A/S stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $202.70 | 0.76% |
| 2028 Feb. | $204.08 | 0.68% |
| 2028 Mar. | $205.29 | 0.59% |
| 2028 Apr. | $206.22 | 0.45% |
| 2028 May. | $206.77 | 0.27% |
| 2028 Jun. | $206.95 | 0.09% |
| 2028 Jul. | $206.84 | -0.05% |
| 2028 Aug. | $206.54 | -0.14% |
| 2028 Sep. | $206.19 | -0.17% |
| 2028 Oct. | $205.93 | -0.13% |
| 2028 Nov. | $205.84 | -0.04% |
| 2028 Dec. | $205.83 | -0.00% |
NVO : Novo Nordisk A/S stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $205.71 | -0.06% |
| 2029 Feb. | $205.41 | -0.15% |
| 2029 Mar. | $204.94 | -0.23% |
| 2029 Apr. | $204.37 | -0.28% |
| 2029 May. | $203.71 | -0.32% |
| 2029 Jun. | $202.94 | -0.38% |
| 2029 Jul. | $202.00 | -0.47% |
| 2029 Aug. | $200.80 | -0.59% |
| 2029 Sep. | $199.27 | -0.76% |
| 2029 Oct. | $197.27 | -1.01% |
| 2029 Nov. | $194.57 | -1.37% |
| 2029 Dec. | $190.97 | -1.85% |
NVO : Novo Nordisk A/S stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $186.40 | -2.39% |
| 2030 Feb. | $180.86 | -2.98% |
| 2030 Mar. | $174.35 | -3.60% |
| 2030 Apr. | $166.95 | -4.24% |
| 2030 May. | $158.65 | -4.98% |
| 2030 Jun. | $148.83 | -6.19% |
| 2030 Jul. | $137.03 | -7.93% |
| 2030 Aug. | $124.20 | -9.37% |
| 2030 Sep. | $111.82 | -9.97% |
| 2030 Oct. | $101.03 | -9.65% |
| 2030 Nov. | $92.45 | -8.49% |
| 2030 Dec. | $86.17 | -6.80% |
NVO : Novo Nordisk A/S stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $81.84 | -5.02% |
| 2031 Feb. | $78.95 | -3.53% |
| 2031 Mar. | $76.87 | -2.63% |
| 2031 Apr. | $75.04 | -2.38% |
| 2031 May. | $73.11 | -2.57% |
| 2031 Jun. | $70.99 | -2.90% |
| 2031 Jul. | $69.15 | -2.59% |
| 2031 Aug. | $68.86 | -0.42% |
| 2031 Sep. | $70.30 | 2.08% |
| 2031 Oct. | $72.55 | 3.21% |
| 2031 Nov. | $75.04 | 3.43% |
| 2031 Dec. | $77.65 | 3.48% |
NVO : Novo Nordisk A/S stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $80.54 | 3.72% |
| 2032 Feb. | $83.57 | 3.75% |
| 2032 Mar. | $86.39 | 3.38% |
| 2032 Apr. | $88.74 | 2.72% |
| 2032 May. | $90.61 | 2.10% |
| 2032 Jun. | $91.99 | 1.53% |
| 2032 Jul. | $92.91 | 1.00% |
| 2032 Aug. | $94.52 | 1.73% |
| 2032 Sep. | $97.20 | 2.84% |
| 2032 Oct. | $98.44 | 1.27% |
| 2032 Nov. | $98.47 | 0.04% |
| 2032 Dec. | $98.09 | -0.39% |
NVO : Novo Nordisk A/S stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $97.31 | -0.79% |
| 2033 Feb. | $96.25 | -1.08% |
| 2033 Mar. | $94.99 | -1.31% |
Frequently Asked Questions about Novo Nordisk A/S stock forecast
Is Novo Nordisk A/S a good long term stock?
From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock can be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2023 Apr. is $141.3997263156 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2024 Mar. is $87.900792464126 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock can be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2027 Mar. is $182.407607073488 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock can be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2028 Mar. is $205.289799018797 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2032 Mar. is $86.3903325867641 From Novo Nordisk A/S stock forecast , Novo Nordisk A/S (NVO) stock cannot be a good investment choice. According to Tudal, the Novo Nordisk A/S stock price forecast for 2033 Mar. is $94.9938817066628
Is Novo Nordisk A/S stock overvalued?
Novo Nordisk A/S (NVO) stock is expected to go DOWN . Therefore, Tudal would say that Novo Nordisk A/S (NVO) stock is overvalued.
Will Novo Nordisk A/S stock price go up?
No. The Novo Nordisk A/S stock price forecast for 2024 Mar. is $87.900792464126
Is Novo Nordisk A/S stock a good buy now?
Since closing price on 2023-03-17 is $139.440002441406 and forecast for 2024 Mar. is $87.90, Novo Nordisk A/S stock is not a good 1 year investment.